Clopidogrel Resistance: Barrier to Effective Antiplatelet Therapy After Off-Pump Coronary Artery Bypass Grafting

Ann Thorac Surg. 2023 May;115(5):1134-1135. doi: 10.1016/j.athoracsur.2022.11.017. Epub 2022 Nov 29.

Authors

Qiudong Chen¹, Michael E Bowdish²

Affiliations

¹ Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, 127 S San Vicente Blvd, AHSP Ste A3100, Los Angeles, CA 90048.
² Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, 127 S San Vicente Blvd, AHSP Ste A3100, Los Angeles, CA 90048. Electronic address: michael.bowdish@cshs.org.

PMID: 36460067
DOI: 10.1016/j.athoracsur.2022.11.017

No abstract available

Publication types

Comment

MeSH terms

Aspirin
Clopidogrel / therapeutic use
Coronary Artery Bypass, Off-Pump*
Humans
Platelet Aggregation Inhibitors* / therapeutic use
Treatment Outcome

Substances

Clopidogrel
Platelet Aggregation Inhibitors
Aspirin